Skip to main content
. 2017 Oct 19;7:13575. doi: 10.1038/s41598-017-14148-8

Figure 2.

Figure 2

Stimulation of recombinant TFPI-2 (rTFPI-2) inhibits proliferation and invasion of breast cancer cells. (A) ELISA assays indicate the relative levels of secreted TFPI-2 in the culture medium of stable MDA231 cell lines. Data were analyzed from three independent experiments.*P < 0.05 as determined by Student’s t-test. (B) ELISA assays show that the levels of TFPI-2 in culture medium of MDA231 cells were higher than that in MCF7 cells (~6.85 fold). Data were analyzed from three independent experiments. **P < 0.01 as determined by Student’s t-test. (C) Effect of exogenously offered rTFPI-2 on proliferation of MCF7 cells. MCF7 cells were cultured in the medium containing various concentrations of rTFPI-2 (0, 6.25, 12.5, 25, 50ng/ml). Cell viability was measured by MTT assays at the time of 2, 24, 48, and 72hrs. P < 0.05. (D) Transwell assays show the invasive capacity of MCF7 cells after incubation with exogenous rTFPI-2 (0, 12.5, 25, 50ng/ml). Representative images of the assays were shown and statistical data were analyzed from three independent experiments. *P < 0.05 as determined by one-way ANOVA followed by Tukey’s multiple comparison tests.